Does TOFACITINIB Cause Rectal haemorrhage? 644 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 644 reports of Rectal haemorrhage have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.4% of all adverse event reports for TOFACITINIB.
644
Reports of Rectal haemorrhage with TOFACITINIB
0.4%
of all TOFACITINIB reports
167
Deaths
257
Hospitalizations
How Dangerous Is Rectal haemorrhage From TOFACITINIB?
Of the 644 reports, 167 (25.9%) resulted in death, 257 (39.9%) required hospitalization, and 182 (28.3%) were considered life-threatening.
Is Rectal haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 644 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Rectal haemorrhage?
RIVAROXABAN (4,501)
ASPIRIN (3,057)
ADALIMUMAB (2,629)
VEDOLIZUMAB (2,163)
INFLIXIMAB (1,554)
CLOPIDOGREL BISULFATE (1,333)
APIXABAN (1,177)
WARFARIN (1,174)
PREDNISONE (1,098)
MESALAMINE (990)
Which TOFACITINIB Alternatives Have Lower Rectal haemorrhage Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN